Received: 24 January 2019
Accepted: 17 May 2019
First Online: 28 May 2019
Ethics approval and consent to participate
: The Ethics Committee of Padova University Hospital (prot. 2606-12P) approved this study, which was made according to the Declaration of Helsinki and local legislation. The patients included in the study gave written informed consent to all procedures and they agreed with the anonymous use of their data for scientific aims and publication.
: Not applicable.
: SGP: had received speaker fees and research funding from Gilead Sciences, ViiV Healthcare, Abbott, Abbvie, Janssen, Merck Sharp & Dohme.MB: had received speaker fees from Gilead Sciences.L.S. had received travel grants from Gilead Sciences and Merck Sharp & Dohme.MA: had received speaker fees, travel grants, and consulting fees from Abbvie, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, and Janssen-Cilag.Other Authors declared they have no competing interests.